Mitochondrial oxidative phosphorylation in cutaneous melanoma

Area of Science:

• Oncology
• Cancer Metabolism
• Mitochondrial Biology

Background:

• The Warburg effect, characterized by glycolysis upregulation in tumor cells, was historically considered primary for ATP generation.
• Recent research highlights the crucial role of oxidative phosphorylation (OXPHOS) alongside glycolysis in cancer cell metabolism.
• Melanoma exhibits metabolic plasticity, dynamically shifting between glycolysis and OXPHOS, and metabolic symbiosis, upregulating both pathways for survival and chemoresistance.

Purpose of the Study:

• To review the significance of metabolic plasticity and symbiosis in melanoma progression.
• To elucidate the role of mitochondrial transfer from mesenchymal stromal cells (MSCs) to melanoma cells.
• To explore mitochondrial trafficking as a therapeutic target for melanoma.

Main Methods:

• Review of scientific literature on melanoma metabolism, the tumor microenvironment (TME), and mitochondrial dynamics.
• Analysis of the interplay between melanoma cells and MSCs within the TME.
• Examination of the mechanisms underlying metabolic symbiosis and mitochondrial transfer.

Main Results:

• Melanoma cells display significant metabolic plasticity and symbiosis, crucial for progression and chemoresistance.
• Mesenchymal stromal cells (MSCs) in the TME support melanoma progression through a symbiotic relationship.
• Mitochondrial transfer from MSCs to melanoma cells is a key mechanism enabling melanoma cells to regain OXPHOS capacity, even with mitochondrial mutations.

Conclusions:

• Mitochondrial transfer from MSCs to melanoma cells is a critical factor in melanoma progression and therapeutic resistance.
• Targeting mitochondrial trafficking presents a promising novel therapeutic strategy for advanced melanoma.